» Articles » PMID: 17069896

In Vitro Improvement of a Shark IgNAR Antibody by Qbeta Replicase Mutation and Ribosome Display Mimics in Vivo Affinity Maturation

Overview
Journal Immunol Lett
Date 2006 Oct 31
PMID 17069896
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We have employed a novel mutagenesis system, which utilizes an error-prone RNA dependent RNA polymerase from Qbeta bacteriophage, to create a diverse library of single domain antibody fragments based on the shark IgNAR antibody isotype. Coupling of these randomly mutated mRNA templates directly to the translating ribosome allowed in vitro selection of affinity matured variants showing enhanced binding to target, the apical membrane antigen 1 (AMA1) from Plasmodium falciparum. One mutation mapping to the IgNAR CDR1 loop was not readily additive to other changes, a result explained by structural analysis of aromatic interactions linking the CDR1, CDR3, and Ig framework regions. This combination appeared also to be counter-selected in experiments, suggesting that in vitro affinity maturation is additionally capable of discriminating against incorrectly produced protein variants. Interestingly, a further mutation was directed to a position in the IgNAR heavy loop 4 which is also specifically targeted during the in vivo shark response to antigen, providing a correlation between natural processes and laboratory-based affinity maturation systems.

Citing Articles

Research progress on unique paratope structure, antigen binding modes, and systematic mutagenesis strategies of single-domain antibodies.

Liu C, Lin H, Cao L, Wang K, Sui J Front Immunol. 2022; 13:1059771.

PMID: 36479130 PMC: 9720397. DOI: 10.3389/fimmu.2022.1059771.


Ancient species offers contemporary therapeutics: an update on shark V single domain antibody sequences, phage libraries and potential clinical applications.

English H, Hong J, Ho M Antib Ther. 2020; 3(1):1-9.

PMID: 32118195 PMC: 7034638. DOI: 10.1093/abt/tbaa001.


Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody.

Cheong W, Leow C, Majeed A, Leow C Int J Biol Macromol. 2020; 147:369-375.

PMID: 31926922 PMC: 7112388. DOI: 10.1016/j.ijbiomac.2020.01.039.


Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF Neutralization.

Camacho-Villegas T, Mata-Gonzalez M, Garcia-Ubbelohd W, Nunez-Garcia L, Elosua C, Paniagua-Solis J Mar Drugs. 2018; 16(4).

PMID: 29614715 PMC: 5923400. DOI: 10.3390/md16040113.


Beyond antibody engineering: directed evolution of alternative binding scaffolds and enzymes using yeast surface display.

Konning D, Kolmar H Microb Cell Fact. 2018; 17(1):32.

PMID: 29482656 PMC: 6389260. DOI: 10.1186/s12934-018-0881-3.